ATE22564T1 - O-acyl-alkandiol-phospholipide, verfahren zu ihrer herstellung und sie enthaltende pharmateutische zusammensetzungen. - Google Patents

O-acyl-alkandiol-phospholipide, verfahren zu ihrer herstellung und sie enthaltende pharmateutische zusammensetzungen.

Info

Publication number
ATE22564T1
ATE22564T1 AT84102005T AT84102005T ATE22564T1 AT E22564 T1 ATE22564 T1 AT E22564T1 AT 84102005 T AT84102005 T AT 84102005T AT 84102005 T AT84102005 T AT 84102005T AT E22564 T1 ATE22564 T1 AT E22564T1
Authority
AT
Austria
Prior art keywords
carbon atoms
residue
alkanediol
acyl
preparation
Prior art date
Application number
AT84102005T
Other languages
English (en)
Inventor
Hans-Heiner Dr Lautenschlaeger
Erich Dr Graf
Sigurd Dr Leyck
Original Assignee
Nattermann A & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nattermann A & Cie filed Critical Nattermann A & Cie
Application granted granted Critical
Publication of ATE22564T1 publication Critical patent/ATE22564T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/132—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
    • C07C29/136—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
    • C07C29/147—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of carboxylic acids or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C31/00—Saturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C31/18—Polyhydroxylic acyclic alcohols
    • C07C31/20—Dihydroxylic alcohols
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/178—Unsaturated ethers containing hydroxy or O-metal groups
    • C07C43/1782—Unsaturated ethers containing hydroxy or O-metal groups containing six-membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT84102005T 1983-03-05 1984-02-25 O-acyl-alkandiol-phospholipide, verfahren zu ihrer herstellung und sie enthaltende pharmateutische zusammensetzungen. ATE22564T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19833307925 DE3307925A1 (de) 1983-03-05 1983-03-05 Neue 0-acyl-alkandiol-phospholipide, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
EP84102005A EP0121088B1 (de) 1983-03-05 1984-02-25 O-Acyl-Alkandiol-Phospholipide, Verfahren zu ihrer Herstellung und sie enthaltende pharmateutische Zusammensetzungen

Publications (1)

Publication Number Publication Date
ATE22564T1 true ATE22564T1 (de) 1986-10-15

Family

ID=6192681

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84102005T ATE22564T1 (de) 1983-03-05 1984-02-25 O-acyl-alkandiol-phospholipide, verfahren zu ihrer herstellung und sie enthaltende pharmateutische zusammensetzungen.

Country Status (6)

Country Link
US (1) US4610979A (de)
EP (1) EP0121088B1 (de)
JP (1) JPS59170097A (de)
AT (1) ATE22564T1 (de)
DE (2) DE3307925A1 (de)
ZA (1) ZA841533B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3662197D1 (en) * 1985-07-15 1989-04-06 Takeda Chemical Industries Ltd 2-alkanoyloxypropane derivatives, their production and use
IE59664B1 (en) * 1985-12-04 1994-03-09 Max Planck Gesellschaft Phosphorus-containing organic compounds, process for the preparation thereof and medicaments containing them
US5185334A (en) * 1989-07-31 1993-02-09 Schering Corporation 2,2-disubstituted glycerol and glycerol-like compounds, compositions and methods of use
US5290769A (en) * 1989-09-27 1994-03-01 Asta Pharma Aktiengesellschaft Use of hexadecylphosphocholine for the treatment of psoriasis
JP2512019Y2 (ja) * 1991-01-31 1996-09-25 三菱重工業株式会社 容器洗浄装置
DE4234130A1 (de) * 1992-10-09 1994-04-14 Max Planck Gesellschaft Phospholipase A¶2¶ inhibierende Phosphatidylcholinverbindungen
GB9301702D0 (en) * 1993-01-28 1993-03-17 Biocompatibles Ltd New materials
US8071740B2 (en) 2000-11-17 2011-12-06 Vascular Biogenics Ltd. Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
US6838452B2 (en) 2000-11-24 2005-01-04 Vascular Biogenics Ltd. Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
IL156015A0 (en) * 2000-11-24 2003-12-23 Vascular Biogenics Ltd Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
EP1436313B1 (de) 2001-10-19 2010-09-22 Vascular Biogenics Ltd. Polynukleotidkonstrukte, pharmazeutische zusammensetzungen und verfahren zur gezielten herunterregulierung von angiogenese und zur krebstherapie
US7807847B2 (en) 2004-07-09 2010-10-05 Vascular Biogenics Ltd. Process for the preparation of oxidized phospholipids
US9006217B2 (en) 2007-01-09 2015-04-14 Vascular Biogenics Ltd. High-purity phospholipids
US8569529B2 (en) 2007-01-09 2013-10-29 Vascular Biogenics Ltd. High-purity phospholipids
KR100951108B1 (ko) * 2008-04-15 2010-04-07 엔자이텍 주식회사 라세믹 또는 광학적으로 활성이 있는 α-글리세로포스포릴콜린 및 그 유도체의 제조방법
KR20110095288A (ko) 2008-11-06 2011-08-24 바스큘라 바이오제닉스 리미티드 산화된 지질 화합물 및 이의 용도
US9771385B2 (en) 2014-11-26 2017-09-26 Vascular Biogenics Ltd. Oxidized lipids
CN106999506A (zh) 2014-11-26 2017-08-01 脉管生物生长有限公司 氧化脂质以及纤维化的治疗或预防
ES2739773B2 (es) * 2018-08-02 2020-11-17 Univ Alicante Compuestos zwitterionicos de acidos 2-fosfocolina carboxilicos y su uso como agentes citotoxicos

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3542820A (en) * 1968-10-08 1970-11-24 American Home Prod Alpha,omega - alkanediolphosphorylalkanolamine derivatives and process for preparing thereof
DE2345057C3 (de) * 1973-09-06 1982-05-13 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Verfahren zur Herstellung von Propandiol (1,3)-phosphatiden
US4408052A (en) * 1980-02-27 1983-10-04 Takeda Chemical Industries, Ltd. Phospholipid carbamates
US4493832A (en) * 1981-07-03 1985-01-15 Fujisawa Pharmaceutical Co., Ltd. Certain glycerol-phosphoryl choline derivatives, compositions containing same and method of using same

Also Published As

Publication number Publication date
DE3460843D1 (en) 1986-11-06
ZA841533B (en) 1984-10-31
DE3307925A1 (de) 1984-09-06
JPS59170097A (ja) 1984-09-26
EP0121088B1 (de) 1986-10-01
EP0121088A1 (de) 1984-10-10
US4610979A (en) 1986-09-09

Similar Documents

Publication Publication Date Title
DE3460843D1 (en) New o-acyl-alkanediol-phospholipids, processes for their preparation and pharmaceutical preparations containing them
ATE78259T1 (de) 9-(phosphonylmethoxyalkyl)-adenine, verfahren zu ihrer herstellung und ihre verwendung.
ES483511A1 (es) Un procedimiento para la preparaion de nuevas espiro-oxazo- lidinohoinas.
ATE21699T1 (de) Verfahren zur herstellung von 2-penemverbindungen.
DE122009000040I2 (de) Naphthalin-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen.
KR840000515A (ko) N-아릴-피페라진알칸아미드의 제조법
ES483767A1 (es) Procedimiento para producir n-arilsulfonil-l-argininamidas
ATE19066T1 (de) 1,3-dihydro 4-(1-hydroxy-2-aminoethyl)2-h-indol-2-on-deriva e, ihre saelze, verfahren zu ihrer herstellung, verwendung als heilmittel und zusammenstellungen die sie enthalten.
ES8704917A1 (es) Procedimiento para prepararar derivados de 1-piperazinacarboximida.
MD422C2 (ro) Derivaţi ai azolului şi compuţi intermediari pentru producerea lor
SE8306370D0 (sv) Novel androstane-17beta-carboxylic acid esters, a process and intermediates for their preparation, compositions and method for the treatment of inflammatory conditions
ATE35133T1 (de) N-substituierte (bis(hydroxymethyl)-methyl>isochinolinderivate, verfahren zu ihrer herstellung und pharmazeutische zubereitungen, die sie enthalten.
ATE72247T1 (de) Estran- und androstan-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende praeparate.
ES8304916A1 (es) Procedimiento para preparar esteres de 2-nitro-5(fenoxi sus-tituido-benzoato de alfa-hidroxialcanoatos)
AU539348B2 (en) 5,6,8,9-tetrahydro-7h-dibenz(d,f)azonine derivatives
ATE8257T1 (de) Verfahren zur herstellung von 4-chinolinonen.
ATE19879T1 (de) Furyloxazolylessigsaeure-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
NZ189091A (en) Prostaglandin derivatives
ES8609184A1 (es) Procedimiento de preparar agentes de fluoracion de compuestos organicos.
DE69007203D1 (de) Imidazolderivate, Verfahren zu deren Herstellung und diese enthaltende Antiulkusmittel.
ATE28327T1 (de) 1-piperazinocarboxylate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE36321T1 (de) (bis(substituiertes methyl)methyl>isochinolinderivate, verfahren zu ihrer herstellung und pharmazeutische zubereitungen, die sie enthalten.
DE68926016D1 (de) Halogeno-4-Methylpyrazole und Verfahren zu ihrer Herstellung
ATE1643T1 (de) Silyl-benzimidazol-2-carbaminsaeureester, verfahren zu ihrer herstellung und ihre verwendung als fungizide.
ATE34740T1 (de) (bis(hydroxymethyl)methyl)-isochinolinderivate, verfahren zu ihrer herstellung und pharmazeutische zubereitungen, die sie enthalten.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee